How did the arsenic compound Salvarsan contribute to the treatment of syphilis?

Developed in 1909 by the German scientist Paul Ehrlich and his colleague Sahachiro Hata, Salvarsan—also known as arsphenamine or "606"—was a synthetic preparation containing arsenic that revolutionized the treatment of syphilis.123

Salvarsan was significant because it was the first drug capable of attacking the spirochete Treponema pallidum, the microorganism responsible for syphilis, directly. Ehrlich, who sought a "magic bullet" that could destroy infectious agents without harming the patient, found that this arsenic compound was lethal to the bacteria while remaining relatively harmless to the human host.123

Its introduction in 1910 inaugurated the chemotherapeutic era, providing a standard treatment that helped bring the disease under control until the later development of penicillin. By offering an effective pharmacological alternative to earlier, less successful methods, Salvarsan played a critical role in the history of medicine and the management of infectious diseases.134